The fight against Tuberculosis (TB), a contagious disease primarily affecting the lungs, continues to evolve with advancements in diagnostic techniques. This article reviews the latest developments in TB detection, focusing on their efficacy and potential impact on patient outcomes.
Introduced in 2010, the GeneXpert MTB/RIF test revolutionized TB diagnostics. This molecular test identifies Mycobacterium tuberculosis and resistance to rifampicin in less than two hours. Its high sensitivity and specificity, even in smear-negative samples, make it a valuable tool in TB control, particularly in HIV co-infection and paediatric cases.
Line Probe Assays (LPAs) are another significant advancement. These molecular techniques detect specific genetic mutations associated with drug resistance. WHO has endorsed LPAs for the detection of multidrug-resistant TB (MDR-TB) due to their rapid turnaround time and high accuracy.
Next-Generation Sequencing (NGS) is a promising method for TB diagnosis. It allows comprehensive analysis of the entire Mycobacterium tuberculosis genome, providing information about drug resistance and genetic diversity. Although still in research phases, NGS has the potential to become a 'one-stop-shop' for TB diagnosis and drug susceptibility testing.
Advancements in imaging techniques, like the introduction of digital radiography and computer-aided detection, have improved the accuracy of TB diagnosis. These technologies offer better image quality and interpretation, aiding early detection and treatment initiation.
While smear microscopy and culture remain the backbone of TB diagnosis, these advancements offer faster, more accurate detection. They also provide insights into drug resistance, crucial for improving treatment strategies. As we continue to strive for TB elimination, embracing these innovative diagnostic approaches will be instrumental in achieving this goal.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation